Search results
Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel...
Zacks via Yahoo Singapore Finance· 8 months agoFor Immediate Release Chicago, IL – October 31, 2023 – Today, Zacks Equity Research discusses Dr....
Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO
Zacks via Yahoo Singapore Finance· 2 years agoTeva Pharmaceutical Industries Limited TEVA announced that it has appointed Richard Francis as its...
The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance...
Zacks via Yahoo Singapore Finance· 7 months agoFor Immediate Release Chicago, IL – November 21, 2023 – Zacks.com announces the list of stocks...
Novartis' (NVS) Shareholders Approve Sandoz Separation
Zacks via Yahoo Singapore Finance· 10 months agoNovartis AG NVS announced that its shareholders agreed to the proposed 100% spin-off of its generic...
Novartis CFO: improved outlook for Sandoz has no impact on strategic review
Reuters via Yahoo Singapore Finance· 2 years agoFRANKFURT (Reuters) - An improved earnings outlook for Sandoz, the generic-drug unit of Swiss...
Novartis plans to close a Sandoz plant in North Carolina
Reuters via Yahoo News Singapore· 2 years agoPharmaceuticals company Novartis plans to close a Sandoz generics plant in Wilson, North Carolina,...
Novartis (NVS) Plans to Spin Off Generics Business Sandoz
Zacks via Yahoo Singapore Finance· 2 years agoNovartis NVS has announced plans to spin off Sandoz, its generics and biosimilars division, into a...
A Note On Sandoz Group AG's (VTX:SDZ) ROE and Debt To Equity
Simply Wall St. via Yahoo Singapore Finance· 6 months agoMany investors are still learning about the various metrics that can be useful when analysing a...
Novartis to spin off generics business Sandoz next year
Reuters via Yahoo Singapore Finance· 2 years agoZURICH/LONDON (Reuters) -Novartis plans to spin off its underperforming generics unit Sandoz to...
Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates
Zacks via Yahoo Singapore Finance· 2 years agoNovartis (NVS) plans to spin off its generics division, Sandoz. The FDA approves J&J (JNJ) and...